Username:
Password:
   
Create an Account
 
Account
Curriculum
Transcript
Preferences
 
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
 
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
 
Anesthesiology Update 2017
Activity Details
Activity Name: Anesthesiology Update 2017
Needs Assessment: There will be an estimated 3.5 milling total knee arthroplasties performed by 2030. Out-patient surgery traditionally reduces cost by up to 30%, so there is a huge potential for cost savings. Recent advances in surgical technique. anesthesia and protocol driven care have allowed this procedure to potentially be performed with a shorter length stay. It is desirable to try and reduce length of stay to try and minimize health care costs, without increasing readmission rate, and complications. Identifying patient factor which are associated with successful date case knee arthroplasty is important. Although "multi-modal analgesia" is a current trend in anesthesia care, the use of adjunct medication is not consistent. This is especially true concerning ketamine. This is related to contradictory information and teaching, both past and present:
  • Various publications suggest perioperative ketamine may reduce acute opioid requirements. But the protocols are doses differ widely
  • Anesthesiologists are most familiar with ketamine as a sedative/hypnotic/anesthetic
  • At moderate dosed ketamine use is linked to dysphoria and agitation
  • Low dose ketamine has limited effect in many studies
  • Ketamine use is often not allowed in hospitas outside of the operative/procedural areas
  • Course Objectives:
  • Evaluate the elements of a protocol based pathway aimed for knee arthroplasty
  • Identify patient factors associated with successful day case joint replacement
  • Discuss the barriers to day case joint replacement surgery
  • List the various activities of ketamine at different doses and infusion schemes
  • Identify the unique properties of ketamine that can be used to modify opopod requirements, toleratnce, and hyperalgesia in the perioperative period
  • Develop an active plan to use ketamone in perioperative period to reduce opioid requirements
  • Define point of care viscoelastic testing, and its uses, both Rotational-Thromboelastography (TEG) and Thromboelastometry (ROTEM)
  • Identify clinical scenarios where th euse of TEG and/or ROTEM is appropriate
  • Describe how to use viscoelastic testing for targeted coagulation management massive transfusion events
  • Review TEG and ROTEM analyses and graph interpretation
  • Location Information
    Meeting Location: Monterey Plaza Hotel & Spa
    Meeting Location URL: http://montereyplazahotel.com/
    Location Address: 400 Cannery Row
    Location City: Monterey
    Location State: CA
    Location Postal Code: 93940
    Location Country: US
    Activity Information
    Start Date: 10/27/2017
    End Date: 10/29/2017
    Meeting Size: 125
    Meeting URL: http://www.ucdmc.ucdavis.edu/cme/course_pages/ANEST/anest_pagelink.html
    Credit Information
    Credit Amount: 20
    Credit Unit: Credits
    Accreditation: ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
    Accreditor/Sponsor
    Sponsor Name: UC Davis Health Department of Anesthesiology and Pain Medicine
    Sponsor Address: 4610 X Street, Ste, 2301
    Sponsor City: Sacramento
    Sponsor State: CA
    Sponsor Postal Code: 95817
    Sponsor Country: US
    Sponsor Phone: 916-734-5390
    Sponsor Email: cmereg@ucdavis.edu
    Contact Information
    Contact Name: Vickie Hidalgo
    Contact Email: vmhidalgo@ucdavis.edu

    Type:     Live Meeting
    0 Registered Users